Editor’s Desk The Indian Healthcare Industry is developing and rising at a steady pace. Healthcare is actually one of the main markets, whether we talk about sales or jobs. The growth of the Indian Healthcare sector can be attributed to a variety of factors, such as increasing incomes, increased health awareness, lifestyle diseases, increased access to private sector insurance growth and initiatives taken by the Government of India to promote healthcare. Investments in private sector has seen substantial jump in last couple of years in which some major foreign players have invested in large Indian healthcare firms. Government on its side has set up a variety of initiatives to make healthcare open and affordable to everyone. The Indian healthcare delivery system is categorised into two main components, public and private. The Government, i.e. the public health system, comprises limited secondary and tertiary institutions in key cities and focuses on providing basic healthcare services in the form of primary health centres (PHCs) in rural areas. The private sector provides the majority of secondary, tertiary and quaternary care facilities with a significant concentration in metro, Tier I and Tier II cities. Despite of the above progress made we still are far behind when it comes to providing basic healthcare facilities to all. Our health indicators continue to lag Maternal Mortality Rate, Child Mortality Rate and non-communicable disease burden has increased substantially. The requirements of
beds, doctors and hospitals are all on the lower side as per the standards set by World Health Organization. Till 2014, we have had 0.9 beds per 1000 patients and 0.7 physicians per 1000 patients which are abysmal. Due to this huge gap in infrastructure and inadequate workforce, there is a compound to the problems of the patients. In rural areas of India situation is grimmer only 2 percent doctors live where 68 percent of the total population reside. A new study on access to healthcare facilities shows that rural areas remain significantly underdeveloped in terms of health infrastructure: about half the people in India and over three-fifths of those who live in rural areas have to travel beyond 5 km to reach a healthcare center. In contrast, the urban centers have numerous private hospitals and clinics which provide quality healthcare. These centers have better doctors, access to preventive medicine, and quality clinics. But with increase in urban population density these resources will be insufficient to cater the future demands. Government has started NRHM but the lack of funding is going to hinder the goal of achieving the universal health coverage. To address most of the healthcare delivery issues use of appropriate technology can really help in achieving the goal of universal health coverage. With increase in technology adoption at all levels taking medical facilities to the patients is becoming a reality. Telemedicine is one such medium through which healthcare can be made available at rural and remote area of the country. Telemedicine has been already cited as being particularly helpful in rural areas, where the shortage of healthcare providers had led to a lack of accessibility to both basic healthcare and specialty care. Through telemedicine, patients get access to healthcare faster, which is a leading factor in improved patient engagement and better outcomes. M-health is one more concept which is catching up fast with 684.1 million mobile users & 204.1 million smart phone users this one medium which can be game changer the way healthcare is delivered. Mobile devices have good penetration even in rural areas where other sophisticated infrastructure components do not exist. This growing ubiquity of mobile phones is a central element in the promise of mobile technologies for healthcare sector in India. There are so many apps coming up which provide option to take medical consult via email, call and video call. Of all the new startup coming up 30% are for Healthcare as everybody sees a huge opportunity and a big market in the healthcare delivery space. The overall Indian healthcare market today is worth US$ 100 billion and is expected to grow to US$ 280 billion by 2020, a Compound Annual Growth Rate (CAGR) of 22.9 per cent. Healthcare delivery, which includes hospitals, nursing homes, diagnostics centers, and pharmaceuticals, constitutes 65 per cent of the overall market. Government and private players have great opportunity due to this. Government needs to formulate new inclusive policies and implement the ongoing one effectively. The Healthcare sector needs have to be increased to at least 2.5 percent of GDP. Government should also come up with some plans to standardize and regulate new methods by which healthcare can be delivered through use of technology as right now no such guidelines exist. Government of India intends to introduce a uniform system for maintenance of Electronic Medical Records / Electronic Health Records (EMR / EHR) by the Hospitals and healthcare providers in the country. This needs to implemented and enforced at the earliest as too much time already have been lost on this. At the same time, the government should focus on establishing more medical colleges and training institutes to provide the requisite doctors, dentists, nurses and paramedics. The government also should invest in preventive and social medicine by promoting health education and preventive health-care concepts.
Nishtha Kirtani
- Editor in Chief
Icons Infocom provides Intelligent Solutions that modernize the Health system
Manish R. Goenka CEO, Founder
Our vision is to be recognized as a
one-stop solution provider and we truly believe in that when it comes to disruptive technologies which can bring us closer to our customer and
10 inory
R
in return, they can provide the best of services to their end patients with better quality results and services. We deliver the unexpected when it comes to healthcare services through our
innovative products & services,� says, Manish R. Goenka, CEO & Founder of Icons Infocom Private Limited. Having to come from the Marwari family, business runs in the blood.
September 2020
Manish R. Goenka, a graduate from Mumbai University and later pursued higher studies in Marketing and Sale. At ICONS, Manish’s portfolio includes Dragon, Power PDF, OmniPage, PaperPort, Digital Voice Recorders, and Noise Cancellation Microphones. Manish R. Goenka, says. It’s all started in 1998 when for the 1st time I saw a demo of Dragon Point & Speak, it was kind of love at first sight. It just took me to the world of Startrek, who could ever think about a technology where one speaks and its transcribed as text instantly on the computer screen. Entrepreneurial skill runs in the family, you call the shots, you are the maker of your own fate as your own decisions crave your future. Also, it offers greater rewards for all the hard work and at the same time its’ give work hours flexibility. We started as a small dealer of this software and with team efforts migrated to become a distributor for Mumbai and then the whole of India. Throughout our journey, we meticulously planned entrenched relationships with our customers and sustained all the technology boom and bust cycles. Today, along with our business, our customer base and partnerships have also grown manifold. We not only provide system integration services but also offer distribution and dealership capabilities for hardware and software solutions. Our customers are major players in several market segments and we are the main distribution partners of some of the world’s best-selling brands of leading companies such as Nuance, iStorage, ioSafe, Philips, Andrea, and Asus. With a philosophy built around focus and service, we have established a clear strategy that puts customers at the centre of all our activities. We strive to establish long-term collaborative partnerships with them. We are proud that our customers consider us not just vendors but strategic partners, and have made us what we are. Every Journey has its own challenges,
11 inory
R
in 1990s people generally were not ready to accept new technology, piracy and abuse of licenses. Early years it was more like selling a futuristic solution and although all loved it but not many were willing to buy the license version but with strong cyber laws and greater adaptability and respect for better and faster technology changed the scenario. Well, there’s no single element, Our success combination of many things like a great product, great service and a most importantly great team.
“Our team is our strength when it comes to planning and execution of different strategies for different customs or requirements. Our core team brings in rich experience in healthcare life sciences medical devices and laboratory business. Each one of us focuses on specific roles and responsibilities and freedom drive the organization with their domain knowledge,” he adds. Talking about success and healthcare industry as an Entrepreneur Manish R. Goenka says, the biggest mantra to success is passion, positive attitude, patience and perseverance, if you master these 4 elements, no one can stop your success. The Healthcare industry is growing at a tremendous pace owing to its strengthening coverage, services and increasing expenditure by public as well as private players. The hospital industry in India, accounting for 75% of the total healthcare market, is witnessing a huge investor demand from both global as well as domestic investors, mergers, collaborations are the buzz word. The hospital industry is expected to reach $180-200 bn by 2025 from $ 100-110 bn. The key growth drivers in India today is the Government who is willing to spend and provide policies and
reforms for the development of the industry, Increased Life expectancy, younger generation willing to buy an Insurance policy, Telemedicine and Infrastructure. Starting a business has never been easy but today there are tools available much easier than earlier, it all begins with proper planning, understanding a product, size and a proper road map defining goals. Businesses should be scalable and sustainable. People drive businesses so having a team with a common goal, passion is most important. If you don’t find the right talent seek advice from the industry veterans cause you may have a great idea but not experienced enough to build and scale a product or service. Talking about Business during COVID Pandemic, Manish R. Goenka said. COVID situation has made us go back to the drawing board, it has taught us to start thinking again as we used to think in early years and somewhere down the line your aggression mellows down as you keep achieving things and start embarrassing newer tools. The days are challenging but challenges also get opportunities. We are closely working with many Hospitals, Diagnostic centres and explaining to them the benefit of Speech recognition solution as to how it can benefit their clinicians especially when all have to maintain social distancing and assistive staff may not be around for a while. People are excepting Webinar requests and really don’t want us to physically travel which is a BIG welcome change as it saves time and money which boils down to better productivity and better product cost and pricing to them.
“And equally we are working hard to expand our services as Turnkey project leaders in the healthcare segment to support the growing demand for healthcare service providers,” he concludes.
September 2020
Enhancing Healthcare Facilities and Specialties Amplec Healthcare Pvt. Ltd. is a Pharma company on which you can trust you will be provided the best Pharma products. We have established this company few years back and have become a leading brand in providing highquality lifesaving drugs. Amplec Healthcare Pvt. Ltd. is also known as the most recommended PCD Pharma Company, as we have thousands of satisfied clients who always recommend us. All of the Pharma products we offer are WHO-GMP certified, as we do not compromise with the quality of the Pharma products.
Amplec Healthcare Pvt. Ltd. is leading manufacturers and marketers of Pharmaceutical formulations and recognized in the market, due to our ability to manufacture, export and supply a diverse and qualitative range of Pharma Products like Tablets, Capsules, Soft Gelatines, Oral Liquids, Dry Syrup, Powders, Injections, Sachet. To formulate our range, we use hygienic ingredients that we have sourced from the authentic and reliable vendors of the market who hold rich expertise in this domain. Amplec Healthcare have installed latest and advanced machines to formulate our range as per the industrial standards (GMP Certified). With a worthy 12 inory
R
experience, we provide a wide range of Pharmaceutical Bulk Drugs. These are formulated using superior quality of ingredients at the manufacturers end. We have an expert team of quality controllers, which is responsible to stringently monitor complete ongoing business at each and every stage right from the sourcing of products till the final dispatch at the clients end. Incorporated in the Year of 2018, Amplec Healthcare Pvt. Ltd. manufacturing cum marketing more then 100+ Products in different category like Anti-Biotics, Anti-Bacterial, Anti-Helminthic, Anti-Inflammatory, Anti-Pyretics, Muscle Relaxants, Anti- Fungal, Ayurvidics formulations etc. Amplec Healthcare just focused on the professional approach and quality range of products as per (GMP standards), we have been maintaining a cordial relationship with our clients. With the help of our third-party manufacturing and qualified professionals, we prepare high quality range of pharmaceutical drugs to ensure flawless products. Our ability to deliver bulk quantity of pharmaceutical drugs within a specified time.
“To be one of India’s most admired Company”. We, at Amplec Healthcare are
committed to provide the safe and best quality therapeutic solutions in derma. Apart from this, we are working towards providing rapid and effective access to quality derma product range on time.
Our mission is to be the leading
name in the field of dermatology by formulating products which are innovative, effective, unique and affordable. We want to be known for the excellence in dermatology. Along with this, we want to “To Serve human Beings by delivering innovative & qualitative solutions to their Personal care needs” Our best supply chain services satisfy our clients with fast track supply of Pharma products, as we deliver our products to all the corners of India. Except for this, we also welcome experienced and skilled Pharma professionals who search for the best PCD Pharma franchise companies to start their own Pharma business on monopoly basis, as they want to work as boss of their own company. Amplec Healthcare Pvt. Ltd. provides them all kinds of support so that they could do their Pharma franchise business in a streamline flow. We are one of the fastest growing Pharma Third Party Manufacturing companies in India. We welcome all the brands which want to get external help to make their own September 2020
labelled product’s delivery be on time, as we provide instant solutions by offering high-quality Pharma products to our clients so that they could make their brand status maintained. With our enormous amount of experience as a third-party Pharma manufacturing, none of our client is disappointed by us, as we deliver the products accurately according to our client’s need. Apart from manufacturing general medicines in third party manufacturing. These are one of our finest Pharma productions by producing as thirdparty manufacturers. Amplec Healthcare Pvt. Ltd. is top PCD Pharma Franchise company in the country offer wide range of best quality pharmaceutical products. We have several categories such as Capsules, Syrups, Dry Syrups, Injections, Ointments, Soft Gel Capsules etc.
13 inory
R
September 2020
Biotic Healthcare Working In Support Of Life
B
iotic Healthcare! as our name emulates, we work “In support of life”. Biotic healthcare a leading Pharma Company in India. We are one of the fastest growing Ethical Pharmaceutical company with the vision to cover global markets in healthcare industry. Our Company’s core objective is to provide world-class products to the consumers through its astonishing manufacturing capabilities, branding and marketing of pharmaceutical products in India and Abroad. “Biotic healthcare has been founded by Experienced Pharma Professionals with a vision to support healthcare industry by providing top PCD Pharma Franchise and distribution. With its international presence, Biotic Healthcare products are backed up with GMP and WHO standard manufacturing plants. Our DCGI approved comprehensive range of products covers wide therapeutic 14 inory
R
Sunil Thakral Founder & CEO
September 2020
segment wherein a large number of products are technologically backed up with Bioequivalence studies, which are above par with the leading brands. Being instrumental in Pharma industry’s pursuit to initiate a “Pharmaceutical Revolution” in the country, that is, to bring down prices of medicines, we express utmost optimism that one day… every Indian will have access to all life-saving drugs! Biotic Healthcare management team with more than 15 years of exposure into export and domestic market, commits better product Quality and delivery to the clients. Biotic Healthcare Suppliers and vendors come from blue chip procurement companies and are committed to supply Quality material for our products. The Quality control Team of Biotic Healthcare is committed to maintain good manufacturing practices (GMP Standards) for all our products.
15 inory
R
Sunil Thakral CEO of is the firstgeneration serial entrepreneur with his expertise in business strategy, finance and start-up consultancy. With a comprehensive experience of over 15+ years, spread across eCommerce/IT and Healthcare industry he plays key role in overall business execution. He comes from the core technical background and started his career into Business consultancy but never limited his role to his profile and has explored every aspect of business. He carries great exposure into creating, nurturing and upbringing a company from scratch to the top. Attaining SPEED in our work is one of our natural instincts that helps our clients ascertaining great results in quick time. As a co-founder at Biotic Healthcare Pvt Ltd he has been playing a key role in helping the company meet its local and global objectives. The company is growing at a very fast pace and is able to produce unmatched products for general healthcare.
Sunil Thakral Says, Biotic Healthcare quality assurance is above par because the management of the company is qualified and competent to ensure best quality in its products. We have a set system to maintain standards in manufactured products by testing the samples of output against the specifications provided to the production team. At Biotic Healthcare we leave no stone unturned to ensure the best possible quality control of each and every batch we produce. The Active Pharmaceutical Ingredient (APIs) used in our products have to pass stringent quality checks before getting into production. We believe in keeping high quality in our products so as to transfer maximum efficacy in every drug we manufacture and test at Biotic Healthcare. Our qualified procurement team ensures high efficacy in molecules and excipients used at Biotic.
September 2020
The Ultimate Outsourcing Partner to Pharma Industry
PARUL OZA
Managing Director India has emerged as a formidable player in Active Pharmaceutical Ingredients (API), Key Intermediates and Formulations. Most of the countries across the globe consider India as one of the major sourcing bases as India has largest number of USFDA approved facility outside the USA. International and Indian pharmaceutical companies face enormous challenges in terms of changing norms/regulations in the outsourcing process. Therefore, to stay ahead of the competition, 16 inory
R
it becomes important for the pharmaceutical companies to have pool of experts by their side. Many Indian pharmaceutical companies, especially midsized companies have good approvable or approved manufacturing facilities, qualified manpower, good technical knowhow, etc. On the other hand, International companies face challenges in identifying reliable quality supplier /manufacturer. CRMO has been working in the space for more than 20+ years bridging this gap between the
Indian and International market by providing complete outsourcing solutions to Pharmaceutical industry. CRMO Pharmmatecch is Ahmedabad, India based company established with a vision of providing complete outsourcing solutions to Pharmaceutical Industry. CRMO’s primary focus is to help companies identify suitable outsourcing partners and manage entire sourcing project including QC/QA audits, facility audits, technology transfer ,supply chain September 2020
management, project coordination, and responsible care for the clients. CRMO’ s workforce keeps itself updated on trends in pharmaceutical market, API and Formulation technology, intellectual property, regulatory guideline, cGMP and SHE( safety , health and environment) . CRMO has to her credit, successful implementation and execution of many outsourcing and technology transfer projects/assignments for the clients worldwide. The products range from KSMs of In-patent APIs, Generic APIs, KSMs thereof, to various Formulations. Situated in India’s Pharma hub, CRMO is managed by highly experienced, energy driven, techno-commercial professionals having vast experience in the field of Outsouring, Contract research and Contract manufacturing sector in pharmaceutical industry. Leveraging years of experience and knowledge of the Indian and International markets to find the best solution for the customers. The company leaves no stone unturned to help International clients identify suitable outsourcing partners and manage entire sourcing including QC/QA audits, facility audits, technology transfer, supply chain management, project coordination, and provide responsible care for the clients. From identifying a suitable manufacturing site, to helping them on behalf of clients in cGMP compliances, regulatory approvals, facility modification and auditing the production site, CRMO provide complete outsourcing solution which is very important for any pharmaceutical industry to maintain quality at all times, thereby helping clients attain sourcing goals. 17 inory
R
CRMO offers consulting services covering Current Good Manufacturing Practices(cGMP), Quality Management including all aspects of Good Laboratory Practice (GLP), Validation and Qualification as well Regulatory agency Documentation. We have wide experience in Indian and International market and we fully understand the requirements of Regulatory agencies such as USFDA, EDQM, MHRA, TGA, etc. Our practical work experience with such agencies has resulted into huge success rate. This has been possible due to our successful working relationships with reputed Indian Pharmaceutical Companies. Our services ensure overall cost containment for our customers with maximum deliverables investing minimum resources. CRMO maintains a panel of experts from both the USA and India and our practical work experience with all regulatory agencies has resulted in a high success rate for our clients. India is proving out to be a preferred outsourcing location for many Pharmaceutical companies. It is a member of the BRIC countries and is one of the most important Pharmerging market. Due to the availability of the large English-speaking scientific talent pool, India offers end to end solution across the drug development spectrum including drug discovery; clinical trials; contract manufacturing, product licensing and commercial supply. Indian Pharma Sector shows Sound understanding of global regulatory benchmarks. Having larger number of USFDA approved sites in India biggest number other than the US - is a testimony to this fact. It offers strong manufacturing bases with flexible approach for partnering
through tech transfer, product inlicensing and contract research and manufacture and has a comparable business philosophy to western world. However, outsourcing to India is not without its own Challenges. Geopolitically and culturally diverse India poses its own complexities to the companies looking for outsourcing. Success of any Outsourcing Project requires streamlined and uninterrupted work flow, strong interface between the manufacturers and suppliers and minimizing the cultural differences between the east and the west. Therefore, a local presence at the suppliers’ end to manage the customer’s outsourcing activity can help complete their projects on time. As opposed to the internal project managers, external project managers can have a very unbiased and wholesome outlook for Project completion. CRMO offers unmatched pharmaceutical project management services to the International Pharmaceutical Industry.
We feel that we are well positioned to take care of diverse contract manufacturing and Pharmaceutical technology transfer project management activities.
September 2020
Using artificial intelligence-internet of things (AI-IoT) in COVID-19 pandemic situation for healthcare workers In this worldwide health crisis, the medical industry is looking for new technologies to monitor and controls the spread of COVID-19 (Coronavirus) pandemic. Healthcare delivery requires the support of new technologies like Artificial Intelligence (AI), Internet of Things (IoT), Big Data and Machine Learning to fight and look ahead against the new diseases. AI is one of such technology which can easily track the spread of this virus, identifies the highrisk patients, and is useful in controlling this infection in realtime. It can also predict mortality risk by adequately analyzing the previous data of the patients. AI can help us to fight this virus by population screening, medical help, notification, and suggestions about the infection control. This technology has the potential to improve the planning, treatment and reported outcomes of the COVID-19 patient, being an evidence-based medical tool. shows the general procedure of AI and non-AI based applications that help general physicians to identify the COVID-19 symptoms. Applications of AI in COVID-19 pandemic I)Early detection and diagnosis of the infection AI can quickly analyse irregular 18 inory
R
symptom and other ‘red flags’ and thus alarm the patients and the healthcare authorities. It helps to provide faster decision making, which is cost-effective. It helps to develop a new diagnosis and management system for the COVID 19 cases, through useful algorithms. AI is helpful in the diagnosis of the infected cases with the help of medical imaging technologies like Computed tomography (CT), Magnetic resonance imaging (MRI) scan of human body parts. II) Monitoring the treatment AI can build an intelligent platform for automatic monitoring and prediction of the spread of this virus. A neural network can also be developed to extract the visual features of this disease, and this would help in proper monitoring and treatment of the affected individuals. It has the capability of providing day-to-day updates of the patients and also to provide solutions to be followed in COVID-19 pandemic. III) Contact tracing of the individuals AI can help analyse the level of infection by this virus identifying the clusters and ‘hot spots’ and can successfully do the contact tracing of the individuals and also to monitor them. It can predict the future course of this disease and
likely reappearance. IV) Projection of cases and mortality This technology can track and forecast the nature of the virus from the available data, social media and media platforms, about the risks of the infection and its likely spread. Further, it can predict the number of positive cases and death in any region. AI can help identify the most vulnerable regions, people and countries and take measures accordingly. V) Development of drugs and vaccines: AI is used for drug research by analyzing the available data on COVID-19. It is useful for drug delivery design and development. This technology is used in speeding up drug testing in real-time, where standard testing takes plenty of time and hence helps to accelerate this process significantly, which may not be possible by a human. It can help to identify useful drugs for the treatment of COVID-19 patients. It has become a powerful tool for diagnostic test designs and vaccination development. AI helps in developing vaccines and treatments at much of faster rate than usual and is also helpful for clinical trials during the development of the vaccine.
September 2020
VI) Reducing the workload of healthcare workers Due to a sudden and massive increase in the numbers of patients during COVID-19 pandemic, healthcare professionals have a very high workload. Here, AI is used to reduce the workload of healthcare workers. It helps in early diagnosis and providing treatment at an early stage using digital approaches and decision science, offers the best training to students and doctors regarding this new disease. AI can impact future patient care and address more potential challenges which reduce the workload of the doctors. VII)
Prevention of the disease
With the help of real-time data analysis, AI can provide updated
19 inory
R
information which is helpful in the prevention of this disease. It can be used to predict the probable sites of infection, the influx of the virus, need for beds and healthcare professionals during this crisis. AI is helpful for the future virus and diseases prevention, with the help of previous mentored data over data prevalent at different time. It identifies traits, causes and reasons for the spread of infection. In future, this will become an important technology to fight against the other epidemics and pandemics. It can provide a preventive measure and fight against many other diseases. In future, AI will play a vital role in providing more predictive and preventive healthcare. Artificial Intelligence is an
upcoming and useful tool to identify early infections due to coronavirus and also helps in monitoring the condition of the infected patients. It can significantly improve treatment consistency and decision making by developing useful algorithms. AI is not only helpful in the treatment of COVID-19 infected patients but also for their proper health monitoring. It can track the crisis of COVID-19 at different scales such as medical, molecular and epidemiological applications. It is also helpful to facilitate the research on this virus using analyzing the available data. AI can help in developing proper treatment regimens, prevention strategies, drug and vaccine development.
September 2020
MarksMan Healthcare Communications
I
n this progressing and increasingly competitive commercial landscape, attaining optimal market access is becoming extra challenging for pharmaceutical/medical device patrons. In the stir of the global economic crisis, ever increasing costs and abating healthcare budgets, payers have a significant and growing influence on a product’s commercial success. The need to demonstrate clinical and economic evidence of a product to providers, healthcare decisionmakers and payers is becoming the central component to a product’s success. MarksMan Healthcare 20 inory
R
Communications is a Health Economic and Outcomes Research (HEOR), Medical Writing and Data Analytics consulting, committed in providing the highest level of scientific evidence to optimize the value and health impact of medicines and health technologies. We offer customised information solutions for all stages of product’s life-cycle and therapeutic categories. We utilize the expertise of our trained professionals to provide accurate, consistent and concise product, disease and therapeutic area information. Combining backgrounds in medical communications and life
science disciplines with a strong history of high-profile publication, our literature review specialists provide clinical and commercial expertise and analytical synthesis to conduct unbiased systematic, or targeted literature-based research. We can support the creation of reimbursement dossiers across major markets to highlight the value proposition and cost effectiveness of a new drug versus existing treatments. Dimple Arora Co-Founder of MarksMan Healthcare Communications a dynamic MBA professional, having strong analytic and interpersonal skills, with proven track record in leading September 2020
Dr. Amit Dang
Ms. Dimple Arora
Founder & CEO
multinational companies with overseas experience. Skilled in strategic planning, consulting, business development, medicomarketing and talent acquisition. Dr. Amit Dang Founder & CEO of MarksMan Healthcare Communications is the Doctor of Medicine in Pharmacology, university topper, and an entrepreneur by passion, he is also the convener of Indian Medical Advisors Summit (INMAS), Indian Patient Access Summit (iPAS) and the president of ISPOR Mumbai Regional Chapter, India. Dr. Amit Dang says, medical writers team leverages their clinical, medical and regulatory 21 inory
R
Co-Founder
expertise expertise to ensure seamless clinical data management with accuracy of the drug trial and patient safety. We help formulate and put in place strategies and tactics to gain optimal market access for clinical products, ranging from development phase, product launch to post marketing and life cycle management. From clinical research to commercialization, we are facilitators with passion, drive and energy to help bring your product from concept to reality.
and acting as trusted partners. Furthermore, our experienced MDs and PhDs provide in-depth medical knowledge needed for medical review and assessment of safety data. Our aggregate reporting team comprises healthcare professionals and physicians who are well trained and extensively experienced across therapy areas to understand the global regulatory requirements.
Our highly skilled employees, including pharmacists and specialist doctors perform case processing and are committed to meeting our client’s growing needs September 2020
Gap assessment and analysis programme based on NABH: Assessment of infrastructural, human resource and biomedical equipment processes, documentation, orientation of staff and other features with respect to accreditation norms. Assisting on developing plans towards fulfillment of the gaps with hospital staff so that the services offered support accreditation standards. Assistance in developing and reviewing the hospital plan for Accreditation at various stages of the project Orientation, training and assistance towards developing an organizational quality structure and culture that would set the pace for involving and integrating the hospital staff in the accreditation process. Assisting the organization and formulation of committees and teams Guiding on the Development of Quality Assurance Programme Assisting in the Development of Documents, (SOPs, Manuals, Policies, instructions for the hospital, departments aninfection control) modulating the existing system and suggesting changes to support accreditation norms. The required documents will be developed in collaboration with the hospital staff. Assistance in the Development of Record Keeping Programme of the healthcare facility through guidance on the organizing of records, development of formats wherever required and operationalizing of Monitoring system Organization of Training programmes throughout the accreditation preparation process. These training programmes would be generated through, consultant trainers and resources, external trainers and resources, in house facility trainers and resources. Training of pre-identified Hospital staff on NABH methodology for accreditation Development of performance indicators and data collection & its analysis. Facilitation on the development of a facility assessment programme through training of facility staff to conduct assessments, assistance in organizing for internal assessments, facilitation in the conduction of mock drills, internal assessments and assistance in evaluating the results of internal assessment Monitoring of accreditation programme activities, documentation, effectiveness of training programmes and organizing refresher training programmes as per need identified
10Most Pro mising Healthcare Companies In 2020
Green Apple Healthcare, striving for passionately delivering specialty medicines and innovative technological devices for better health outcome. We understand the importance of being more customer centric and service oriented which is a need of the time.
Dr. Michael Nowazek Clinical Director
G
reen Apple Healthcare, striving for passionately delivering specialty medicines and innovative technological devices for better health outcome. We are Embracing excellence to provide care to achieve cure with world class products and services in healthcare industry. Patient centric approach to build better quality of life is our key performance driver. We have established a benchmark for service and operations in the Pharmaceutical industry. To achieve the leadership in healthcare industry and to create customer friendly relationship,
24 inory
R
we have integrated systems surpassing the standards of service, credibility and thereby create better values. For building a community of growth and prosperity in pharmaceutical supply chain, we deal with all kind of Specialty medicines, Hormones & biotechnology drugs, cold chain medicines, Surgical and Medical Devices. Green Apple, as the name suggests “Replenishing the Good Health� which is the pledge of our Directors Mr. Vinayak Chaure and Mr. Vishal Jagdale to achieve leadership through quality health care products and world class services.
The management of any organization plays a key role in the brand building process, thus resulting in its stability and longevity. Mr. Vinayak Chaure and Mr. Vishal Jagdale, are the senior most leader having vast knowledge and experience in the pharmaceutical sector over 11 years. Their functionality is to focus on major financial, strategic and operational decisions of the company. Over 14 year pharmaceutical sales industry veteran, Vinayak has been credited with knowing business inside-out. He started his career with Eli Lilly and then moved on to MSD Pharmaceuticals. He has completed his pharmacy graduation from Pune university and Advanced Executive Program in Management from IIM Lucknow. After working with MNCs in pharmaceutical sales Vinayak Chaure became an entrepreneur through establishment of Green Apple Healthcare Pvt. Ltd. He leads the company with passion and strongly believes in company values. Working with innovative September 2020
lifesaving medicines and devices motivates him to drive the organizational goal of better health outcome
Vinayak Chaure says, we clearly understand the needs and concerns of the healthcare industry so we offer a comprehensive set of services at their disposal. Delivering Innovations for better health outcome. Embrace leadership among India’s top healthcare service providers and establish as a most admirable channel partner to connect innovative specialty medicines and advanced devices keeping patient centric approach. Providing quality products, efficient work and accountability in all we do is utmost priority. We intend to be the best and. ed expectations of stakeholders. Doing the right things for right reasons. Keeping our promise with highest levels of Ethics and integrity standards. We are visionary and bring change. We offer world class medicines and advanced technology in devices to improve health outcome. We are passionate about everything we do. We understand what service means when it comes to serving for healthcare. Our Obsession is to exceed expectations. We thrive on the contributions each person brings to the company by valuing diversity, developing talent, fostering teamwork and rewarding success.
Dr. Briana Botsford and Medical/Surgical Devices. We support aspiration to “achieve better health outcome”. We aspire to relentlessly improve product innovation, customer service and global operational excellence to ensure Green Apple Healthcare’s position as one of the world’s leading providers of all types of pharmaceuticals and devices.
We care the world by work ‘round the clock, across the borders’, just to meet someone’s need. We see possibilities in impossible things and bring them to life. Green Apple Healthcare Pvt. Ltd. is the organization which not only runs for profitability but also make the life of the people happy and safe. Says Vishal Jagdale.
Green Apple Healthcare Pvt. Ltd is a fastest growing service provider in healthcare industry. We deal with Pharmaceuticals 25 inory
R
September 2020
Pacific BPO, an Access Healthcare company, is a leading provider of cost and process optimization solutions to clients in the healthcare industry. We bring technology enabled, and analyticsdriven transformation of revenue cycle processes of physician practices, hospitals, and revenue cycle intermediaries. Our strategic focus on the healthcare industry provides us with domain expertise and best practices that help our clients to -Reduce payroll & operational costs, Boost revenues & maximize shareholder value, Improved patient and physician satisfaction, reduce staffing issues and training time, maximize efficiencies and economies of scale, Improve business service levels. Access Healthcare brings the right people, process, and technology together to streamline your revenue cycle including the various Revenue Cycle Management disciplines that take your valuable 26 inory
R
time away from the patient. The size of the organization does not matter - whether you’re a medical billing company or healthcare system, Access Healthcare’s best practice engine and unique solutions will elevate your revenue cycle to the next level. Kumar Shwetabh is the CEO of Pacific BPO, an Access Healthcare Company, Kumar Shwetabh is responsible for all aspects of company’s business including business development, client relationship management, operations management, training & transition, quality management and Profit and Loss (P/L) management of the organization. Additionally, Kumar is the President of Hospital Business at Access Healthcare. Kumar co-founded Pacific BPO in 2010 and within 8 years, he grew the company from zero to 2,200+ employees. In August 2018, Access Healthcare acquired Pacific BPO to
create one of the largest healthcare revenue cycle management service provider organizations with over 11,000 people. Kumar brings over 15 years of rich experience in sales, account management, transition, and operations management supporting US healthcare provider customers. He has successfully designed and implemented outsourcing solutions for various large hospitals and RCM companies and managed multi-location teams of hundreds of employees and multi-million dollars in revenues. Prior to founding Pacific BPO, Kumar has worked in leadership roles at a Fortune 100 - US-based health insurance company and USfocused revenue cycle management companies. For his outstanding contribution to healthcare outsourcing industry, Kumar has been profiled in various magazines including the Silicon September 2020
Kumar Shwetabh CEO
Review magazine and the BPO Times. Kumar holds an MBA in Marketing and Finance from Symbiosis Institute of Business Management In his free time, Kumar loves reading, writing, traveling and is a movie buff. At Pacific BPO, innovation is our guiding principle. With a rapidly changing and increasingly complex world, we are constantly looking for innovative solutions which will enable us to deliver an increased value and support to our customers. Kumar says, we take pride in our ability to anticipate and take advantage of any future events. This forward-looking approach has prepared us to face challenges of a changing business and competitive environment. Our passion to serve our customers in every possible way and always try to exceed the expectations of 27 inory
R
our customer is the driving force behind our guiding principle of Innovation. We offer our clients a portfolio of services that reflect our expertise, experience and understanding of the business from the BPO perspective. Our deep process expertise and world-class IT skills help our clients to innovate, automate and execute their business processes at lower cost with higher quality. Our key expertise lies in processes such as Medical Coding, Medical Transcription, Medical Billing, Insurance claim Processing, Transaction Processing, and accounting processes. We understand these processes not just from the perspective of execution, but also have a deep understanding of the way in which each of these processes works. Our knowledge and experience have been embedded in a set of
frameworks, templates and best practices. This helps us reduce risk and time to implement and ensures the highest level of quality in offshore BPO engagements with our clients. This focus on quality and consciousness is reflected in our meticulous planning, disaster management, and business continuity plan. But these are only the pillars. We go beyond these standards when it comes to servicing our clients. We make sure we get better at every step and become more intelligent about what we are doing for our clients. We are large enough to be reliable and small enough to be agile and highly responsive. We offer our clients flexible, results-driven engagement options and work as an extended arm of our client’s business. With the ability to quickly ramp up and down teams with skilled professionals, we shorten the time to market for our clients.
September 2020
Unique individuals, unique healthcare needs Each and every one of us is unique. That equally applies to our health, and it’s not just down to our genes or the epigenetics that turn those genes on and off. It is also related to factors such as living in safe housing, benefiting from a steady income, receiving a good education, having access to quality healthcare and adopting healthy lifestyle behaviours, such as eating nutritious food, enjoying good sleep, lowering our stress levels and alcohol-intake. These are what the World Health Organization describes as ‘the social determinants of health’. For chronic diseases, such as diabetes, COPD and congestive heart failure, these factors play a large part in determining the disease’s onset, progression and outcome. If our health is influenced by so many different factors, it follows that optimizing outcomes requires a holistic approach that centers on us as unique individuals. Discharging a patient back home is of little use to them if their home is ill-equipped to cope with their daily needs, or if access to adequate homecare is lacking. Yet today’s hospital systems aren’t
28 inory
R
always centered around people. More often, they are centered around episodic acute care, medical specialisms and technologies – much focus on medical expertise, not enough on people’s health journeys and experiences.
Fortunately, things are beginning to change. Many of the world’s leading care providers have started to organize themselves around their patients’ clinical and social needs, joining the dots between the different disciplines involved in an individual patient’s health journey and combining all the data points – medical, social and environmental – that characterize where the patient has come from, where they are now, and where they are likely to go. What if hospitals could use connected devices and streaming data to monitor patients 24/7 from a virtual care center? What if we could combine personal medical data with socio-economic and behavioural data to predict health risk and potential deterioration? What if family, friends and the community could participate in care? The combined benefits to individuals, their families and to
society at large would be enormous. In addition to providing more personalized and predictive care, there are other good reasons why the current hospital-centric model of care delivery will gradually change. Virtually every country in the developed and developing world is facing rising demand for care from growing and aging populations, coupled with escalating healthcare costs and staff shortages. On its current trajectory, the world will simply not have enough human and financial resources to deliver quality care via the traditional bricks-and-mortar hospital or nursing home model. Several studies have suggested that better care at home for those that represent the largest cost to the system – elderly people with multiple chronic diseases – has a positive impact on patient wellness and stability, while dramatically reducing emergency care and hospital readmissions.
September 2020
29 inory
R
September 2020
Transforming Pharma Engineering through Integrated Turnkey solutions with the idea of providing one stop solution for all pharmaceutical clients, Mr. Shams, current Director of Pharma Access Pvt Ltd., set sail a new path with an aim of providing quality engineering solutions.
Mr. Shams Ahmad Parvaz Director The journey is best measured in the lives one has touched and improved. This is what makes our journey meaningful and worth taking. In 2001, when the Indian Pharmaceutical Industry was on the verge of inflection point 30 inory
R
with global drug manufacturers eyeing for an Indian pie of Drug manufacturing and scouting for partners for their contracting needs, the need for a quality consultant who can cater to various needs of the client was felt and
Starting with the trading of Machine spare parts and then going on to do concept engineering for a brown field pharmaceutical plant and thereafter a green field Pharma facility, Pharma Access started adding services to its portfolio at a breakneck speed to meet the demand for one stop solution. Today we have whole gamut of services to our portfolio for executing a Greenfield Pharmaceutical facility on Turnkey basis. The groundwork for collaboration with various vendors across the globe continued till 2010 while adding major big vendors from Europe mid-way, the major breakthrough happened for Pharma Access in 2010 when we completed a Turnkey facility September 2020
producing 18000 Ampules/hour. There was no looking back since then and today we are a strong 90-member team of experts executing various Turnkey projects around the globe. To build lasting partnerships of trust and respect across the world, through our meticulously delivered solutions, actioned by technological advancement and superior performance. To offer quality driven leadership in technology and turnkey project solutions in the field of pharmaceutical engineering; with unmatched systems of delivery in approach, operations and implementation. Passion, Trust and Quality - We are committed to deliver best in class unmatched quality in all our projects with a passion
31 inory
R
of engineering solutions for a sustainable tomorrow with utmost trust. Mr. Shams, Director of Pharma Access, has been spearheading the company right from 2001 with his vast knowledge of Pharmaceutical engineering and Project execution. He has been a visionary leader who paved the path for Pharma Access to reach where we are today. His efforts have resulted his brainchild, Pharma Access, in making a niche in the market of Turnkey Pharmaceutical Solutions with continued efforts and relentless pursuit for quality and customer centricity. With different companies different USPs to client, it becomes paramount to showcase the model which is market proven as well as cost effective. Pharma Access, thus, has been able to score over
its competitors in its unique model which is not only agile but also GMP centric i.e. every discussion and decision revolves around the GMP Framework. Every business is unique in its nature, goals and direction. We believe that agility of thought and flexibility in execution are two powerful tools in molding solutions. Whatever your problem, our team is here to provide flexible, compliant and future proof solutions based on reliable project execution. We’re passionate about opening new horizons for your business, that’s why we promise more than just solutions to our customers. Our engagement model is tailor made to client’s requirements and thus give a shape of a Turnkey Pharmaceutical project consultant, says Mr. Shams.
September 2020
Leading Pharma PCD Franchise Company
R
emedial Healthcare is one of India’s leading PCD Pharma Company in Ambala (Haryana) manufacturing over 350 different products at WHO compliant and GMP certified facilities. We offer a comprehensive range of products including injections, tablets, capsules, soft-gels syrups, dry syrups, sachets, ointments, lotions, soaps etc. for both domestic and international markets.
delivering best quality of products so as to improve the quality of life of people in a way that constantly inspires us to innovate, achieve excellence and set new benchmarks.
The company was established by a team of visionaries having a very good experience of pharmaceutical manufacturing and marketing. Under these professionals the company is progressing with the remarkable growth rate in the Pharma industry. Everything we do at Remedial Healthcare revolves around extending and improving the quality of life with our products that cover the entire life
We believe in “You are what you do, not what you say you’ll do.” A company’s only continuing resolution should be to deliver better costumer services across individuals, teams or an entire organization. Customer satisfaction and euphoria can take businesses to highest elevation.
The Philosophy of Remedial Healthcare is based on 32 inory
R
By continuously seeking new horizons in human healthcare we strive to become a leading healthcare organization driven through consistent innovative research and technology.
franchise basis with complete monopoly rights and excise free zone benefits. We equip our distributors and franchise partners with the desired marketing & promotional support including visual aids, gift articles, M.R. bags, visiting cards, prescription pads, Products literature, remedial card etc. As an integrated PCD pharma franchise company, we share collaboration and some biotic relationship with our preferred business partners (distributors, sub-distributors, stockists and sub-stockists), all of whom reflect our business ethics, trust, transparency and quality standards.
Remedial Healthcare, one of India’s leading PCD Pharma Franchise Company, offers distributorship of our highquality pharmaceutical products on PCD and pharma September 2020
“The art of medicine consists of amusing the patient while nature cures the disease.� 33 inory
R
September 2020
The rise of Integrated Delivery Networks The drive for efficiency is already leading to consolidation and the growth of Integrated Delivery Networks (IDNs). These are stakeholder groups, such as hospitals, doctors’ offices, homecare providers and payers, that work collaboratively to ensure a more coordinated patient journey. At the same time, a new generation of tech-savvy patients has emerged, who are more than capable of tracking and piloting their own health and wellness. This new breed of healthcare consumer will expect the same convenience in their healthcare experiences that they already get in other aspects of their life, such as their banking or on-line purchasing. In control of their own health data, they will expect to share decision making with healthcare professionals rather than simply ‘doing what the doctor says’. To address these expectations, we already see retailers such as WalMart, CVS, Walgreens, BestBuy and tech companies like Apple, Amazon, Google and Microsoft getting into healthcare. However, improving population health outcomes and reducing costs is not enough. The so-called ‘quadruple aim of healthcare’ also calls for improvement of both the patient and the care professional experience. Studies
34 inory
R
show that patients who have a better experience of care generally have better health outcomes, and healthcare providers that offer a better staff experience benefit from higher quality, lower burn-out rates and lower staff turnover ratios. Philips’ Ambient Experience solutions for radiology departments and its familyfriendly Neonatal Intensive Care Unit (NICU) solutions are good examples of how all four elements of the quadruple aim can come together in an integrated solution. The hospital of the future will no longer be one large building that provides costly in-patient care for a broad range of diseases. Over the next five to ten years, what we conventionally think of as hospitals will increasingly be reserved for the most acutely ill patients and for highly complex procedures. Preventative care and routine treatment for the rest of the patient population will be delivered via connected hubs and spokes in a healthcare network that includes local retail clinics, same-day surgery centers and Cath labs, specialist treatment hubs, freestanding emergency rooms, and even people’s homes – a networked ecosystem joined together by people, places, devices, software and services interwoven
throughout communities. Clinical and Operations (Command) Centers will continuously analyse demand and supply, and the associated patient flows in the network, in real time. They will use AI to provide predictive insights that enable the removal of bottlenecks in care, and use it to identify patterns in the data that support better targeted population health management, helping to identify and protect vulnerable individuals before their health deteriorates. At the same time, virtual care (telehealth) solutions will leverage the network to monitor vulnerable patients 24/7 in their own homes.
September 2020
35 inory
R
September 2020
The Talent Sourcing Partner for Healthcare Industry H
ealthcare is a sunrise industry in South Asia and other emerging markets of the world. The demand for high quality healthcare services is growing exponentially and this has created a huge demand for highly skilled medical and life sciences professionals in healthcare industry. However, there are not many organizations in this part of world that are catering to that need. Salus Healthcare Resources (SHR) is an organization specializing in reducing that gap. Based in Gurgaon, the company was founded in 2010, under the tutelage of its dynamic CEO, Dr. Sachin Gupta. Having recognized the prospect of the healthcare industry, Dr. Sachin floated SHR with the motto of being a crucial player in liaising between the demand and the supply chain of human resources in the field. With both Government and private organizations lining up numerous healthcare delivery projects over the next decade the demand for skilled healthcare manpower including doctors, nurses, paramedical professionals and healthcare managers is going to grow exponentially. Hence, talent acquisition is a challenging prospect for new ventures. This is the area SHR specializes in. “Today, countries across the globe are facing acute shortage of trained healthcare manpower.
36 inory
R
Specifically, in India, the number of physicians per thousand populations in India is 0.6 approximately as compared to 2.7 per thousand in USA and 2.1 per thousand in UK,� elucidated Dr. Sachin. Being a first mover in a market with a niche service offering is a blessing and also poses some challenges. Moreover, the Indian healthcare sector being highly fragmented and unlike the more organized spaces like InfoTech, Telecom or Banking, the initial challenge was penetrating the market, especially in smaller cities. SHR has recognized three core service areas which they specialize in. Firstly, the Leadership Advisory Services which encapsulate helping organizations in recognizing and/or recruiting senior leadership personnel, like CEOs, Medical Directors, Heads of Departments etc. The second in line is the Physician Recruitment Service that enables sourcing of Senior Physicians and Surgeons in various clinical specialties and super specialties. Lastly, the Clinical & Managerial Talent Sourcing deals with identification of suitable candidates for middle level clinical roles in medical, paramedical, nursing and managerial functions. In addition, they have recently expanded their spectrum of services by launching a highly specialized September 2020
Healthcare Mergers and Acquisition Consulting Practice. The M&A practice is expected to grow exponentially over the next few years. SHR’s leadership managerial team and advisors have a vast experience of working closely with some of the biggest names in the healthcare space, and it’s this pool of experience that set SHR apart from others in this rather nascent field. Their unique and holistic understanding of the industry helps them to offer one of the shortest recruitment cycles in healthcare industry in this part of the world, thereby ascertaining financial savings, revenue maximization and better asset utilization. The company has worked with a number of bigwigs across Fortune 500 and NSE/BSE enlistments. Currently they
37 inory
R
are focusing on developing organ transplant program teams and also advising some overseas players on identification of leadership team for their healthcare vertical. “We aim to establish our company as a globally integrated platform for recruitment of physician and healthcare professionals. Going forward, we want to expand to South Asia, Africa, Middle East and Far East. And, also annex and consolidate our position in India especially tier 2 cities,” says Dr. Sachin, while elaborating on the roadmap ahead for SHR. The company aims to replicate the mode of operation and success of the IT industry, in the long run.
September 2020